Skip to content

Dr. Luc Walschot

Active
Private limited company (pre-2019)founded 2018active for 8 yearsSchorsmolenstraat 32, 2800 Mechelen, BelgiumKBO/BCE: BE 0702.746.192

From the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Luc Walschot has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €249,280 and a net result of €228,820. Equity has been growing by about 6.3% per year since 2019. Its solvency ranks better than 43% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 03-09-2018 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.280.601.345 2800 Mechelen, since 03-09-2018
Financial year end
31 December
Peppol
Reachable since 05-01-2026

Board and ownership

Board
  • Walschot LucasDirector · since 03-09-2018

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€314,477
▲ 6.9%
Turnover
≈ €490,000
estimated
Profit
€228,820
▲ 2.3%
Equity
€249,280
▲ 2.1%
Total assets
€459,376
▲ 4.1%
Filed on 28-09-2026, 59 days after the deadlineat the National Bank
Score breakdownraises riskLast filed accounts filed 59 days late; 3 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.16, cash €251,355Equity €249,280 (54.3% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 56% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 79-1
equity 54.3% of total assets
Liquidity 78=
short-term debt 45.7% · cash 54.7%
Profitability 100=
return on assets 49.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: < 0.1%▼ -0.1 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026
Credit of up to €23,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.16 (2.21 in 2024), above the usual 1.5. Short-term debt is 45.7% and cash 54.7% of total assets. 45.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 43% of them on solvency, 59% on liquidity, 80% on profitability and 42% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Last filed accounts filed 59 days late; 3 of the last 3 accounts late
NBB · filings
lowers risk · Liquidity: current ratio 2.16, cash €251,355
NBB · annual accounts
lowers risk · Equity €249,280 (54.3% of total assets)
NBB · annual accounts
raises risk · 2025 accounts filed 59 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-09-2026, 59 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 7 filings
Deviation from the deadline
2025
59 days late
2024
56 days late
2023
58 days late
2022
66 days late
2021
60 days late
2020
8 days early
2019
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 41 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 September (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 90% of companies in human healthsector median €60,139 · 20,665 companies €228,820 View
  • Positive: 7 profitable years in a rowprofit 2025: €228,820 7 years View

Comparable companies

These companies have the same main activity as Dr. Luc Walschot: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €405,000 and €506,000, founded between 2017 and 2019.

CompanyTotal assetsGross margin
Dr. Luc Walschot Mechelen€459,376€314,477
Dr. Brozici Pneumoloog Mol€505,906€314,202
Dr. Jeroen Wens Cardio Antwerpen€404,847€300,801
Dokter Kathleen Goossens, Cardiologie Sint-Katelijne-Waver€411,589€290,323
Dr. Annemie VOET Lille€407,609€310,005
Dr. Hannah Aerts Westerlo€418,232€283,259
Dr. Christophe Breusegem Lievegem€463,170€308,878
Full comparison

Documents

Annual accounts at the NBB

All 7 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Luc Walschot

What is the company number of Dr. Luc Walschot?
The company number of Dr. Luc Walschot is 0702.746.192. The VAT number is the same number with BE in front: BE 0702.746.192.
Where is Dr. Luc Walschot based?
The registered office is at Schorsmolenstraat 32, 2800 Mechelen.Company details
What does Dr. Luc Walschot do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Luc Walschot?
The legal form of Dr. Luc Walschot is Private limited company (pre-2019) (BVBA).
When was Dr. Luc Walschot founded?
Dr. Luc Walschot was founded on 03-09-2018.
Is Dr. Luc Walschot still active?
Yes, Dr. Luc Walschot is an active enterprise in the KBO register.
What is the turnover of Dr. Luc Walschot?
The turnover in financial year 2025 is ≈ €490,000. This figure is estimated from the gross margin of €314,477 and 36 comparable companies (NACE 862). It probably lies between €440,000 and €610,000.Financials
Is Dr. Luc Walschot profitable?
In financial year 2025, Dr. Luc Walschot made a profit of €228,820.
Where can I find the annual accounts of Dr. Luc Walschot?
Dr. Luc Walschot filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Luc Walschot due?
Dr. Luc Walschot must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.